Crossref journal-article
Oxford University Press (OUP)
The Journal of Immunology (286)
Abstract

Abstract The active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), has potent immunomodulatory properties that have promoted its potential use in the prevention and treatment of infectious disease and autoimmune conditions. A variety of immune cells, including macrophages, dendritic cells, and activated T cells express the intracellular vitamin D receptor and are responsive to 1,25(OH)2D3. Despite this, how 1,25(OH)2D3 regulates adaptive immunity remains unclear and may involve both direct and indirect effects on the proliferation and function of T cells. To further clarify this issue, we have assessed the effects of 1,25(OH)2D3 on human CD4+CD25− T cells. We observed that stimulation of CD4+CD25− T cells in the presence of 1,25(OH)2D3 inhibited production of proinflammatory cytokines including IFN- γ, IL-17, and IL-21 but did not substantially affect T cell division. In contrast to its inhibitory effects on inflammatory cytokines, 1,25(OH)2D3 stimulated expression of high levels of CTLA-4 as well as FoxP3, the latter requiring the presence of IL-2. T cells treated with 1,25(OH)2D3 could suppress proliferation of normally responsive T cells, indicating that they possessed characteristics of adaptive regulatory T cells. Our results suggest that 1,25(OH)2D3 and IL-2 have direct synergistic effects on activated T cells, acting as potent anti-inflammatory agents and physiologic inducers of adaptive regulatory T cells.

Bibliography

Jeffery, L. E., Burke, F., Mura, M., Zheng, Y., Qureshi, O. S., Hewison, M., Walker, L. S. K., Lammas, D. A., Raza, K., & Sansom, D. M. (2009). 1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP3. The Journal of Immunology, 183(9), 5458–5467.

Authors 10
  1. Louisa E. Jeffery (first)
  2. Fiona Burke (additional)
  3. Manuela Mura (additional)
  4. Yong Zheng (additional)
  5. Omar S. Qureshi (additional)
  6. Martin Hewison (additional)
  7. Lucy S. K. Walker (additional)
  8. David A. Lammas (additional)
  9. Karim Raza (additional)
  10. David M. Sansom (additional)
References 67 Referenced 635
  1. O'Garra, A., K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6: 458-466. (10.1016/0952-7915(94)90128-7)
  2. Bettelli, E., M. Oukka, V. K. Kuchroo. 2007. TH-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8: 345-350. (10.1038/ni0407-345)
  3. Vogelzang, A., H. M. McGuire, D. Yu, J. Sprent, C. R. Mackay, C. King. 2008. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29: 127-137. (10.1016/j.immuni.2008.06.001)
  4. Happel, K. I., P. J. Dubin, M. Zheng, N. Ghilardi, C. Lockhart, L. J. Quinton, A. R. Odden, J. E. Shellito, G. J. Bagby, S. Nelson, J. K. Kolls. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202: 761-769. (10.1084/jem.20050193)
  5. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240. (10.1084/jem.20041257)
  6. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238. (10.1038/nature04753)
  7. Yu, D., A. H. Tan, X. Hu, V. Athanasopoulos, N. Simpson, D. G. Silva, A. Hutloff, K. M. Giles, P. J. Leedman, K. P. Lam, C. C. Goodnow, C. G. Vinuesa. 2007. Roquin represses autoimmunity by limiting inducible T-cell costimulator messenger RNA. Nature 450: 299-303. (10.1038/nature06253)
  8. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189. (10.1016/j.immuni.2006.01.001)
  9. Manel, N., D. Unutmaz, D. R. Littman. 2008. The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat. Immunol. 9: 641-649. (10.1038/ni.1610)
  10. Marie, J. C., J. J. Letterio, M. Gavin, A. Y. Rudensky. 2005. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201: 1061-1067. (10.1084/jem.20042276)
  11. Fantini, M. C., C. Becker, G. Monteleone, F. Pallone, P. R. Galle, M. F. Neurath. 2004. Cutting edge: TGF-β induces a regulatory phenotype in CD4+CD25− T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153. (10.4049/jimmunol.172.9.5149)
  12. Wan, Y. Y., R. A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102: 5126-5131. (10.1073/pnas.0501701102)
  13. Davidson, T. S., R. J. DiPaolo, J. Andersson, E. M. Shevach. 2007. Cutting edge: IL-2 is essential for TGF-β-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 178: 4022-4026. (10.4049/jimmunol.178.7.4022)
  14. Zheng, S. G., J. Wang, P. Wang, J. D. Gray, D. A. Horwitz. 2007. IL-2 is essential for TGF-β to convert naive CD4+CD25− cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J. Immunol. 178: 2018-2027. (10.4049/jimmunol.178.4.2018)
  15. Setoguchi, R., S. Hori, T. Takahashi, S. Sakaguchi. 2005. Homeostatic maintenance of natural Foxp3+CD25+CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201: 723-735. (10.1084/jem.20041982)
  16. Mucida, D., Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, H. Cheroutre. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260. (10.1126/science.1145697)
  17. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Carcamo, J. Hall, C. M. Sun, Y. Belkaid, F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764. (10.1084/jem.20070590)
  18. Denning, T. L., Y. C. Wang, S. R. Patel, I. R. Williams, B. Pulendran. 2007. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8: 1086-1094. (10.1038/ni1511)
  19. Veldhoen, M., K. Hirota, A. M. Westendorf, J. Buer, L. Dumoutier, J. C. Renauld, B. Stockinger. 2008. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453: 106-109. (10.1038/nature06881)
  20. Quintana, F. J., A. S. Basso, A. H. Iglesias, T. Korn, M. F. Farez, E. Bettelli, M. Caccamo, M. Oukka, H. L. Weiner. 2008. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 453: 65-71. (10.1038/nature06880)
  21. Adorini, L., G. Penna. 2008. Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 4: 404-412. (10.1038/ncprheum0855)
  22. Adams, J. S., M. Hewison. 2008. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab. 4: 80-90. (10.1038/ncpendmet0716)
  23. Penna, G., S. Amuchastegui, N. Giarratana, K. C. Daniel, M. Vulcano, S. Sozzani, L. Adorini. 2007. 1,25-Dihydroxyvitamin d3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 178: 145-153. (10.4049/jimmunol.178.1.145)
  24. Griffin, M. D., N. Xing, R. Kumar. 2003. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu. Rev. Nutr. 23: 117-145. (10.1146/annurev.nutr.23.011702.073114)
  25. Hewison, M., L. Freeman, S. V. Hughes, K. N. Evans, R. Bland, A. G. Eliopoulos, M. D. Kilby, P. A. Moss, R. Chakraverty. 2003. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 170: 5382-5390. (10.4049/jimmunol.170.11.5382)
  26. Bhalla, A. K., E. P. Amento, T. L. Clemens, M. F. Holick, S. M. Krane. 1983. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab. 57: 1308-1310. (10.1210/jcem-57-6-1308)
  27. Griffin, M. D., W. Lutz, V. A. Phan, L. A. Bachman, D. J. McKean, R. Kumar. 2001. Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98: 6800-6805. (10.1073/pnas.121172198)
  28. Adorini, L., N. Giarratana, G. Penna. 2004. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin. Immunol. 16: 127-134. (10.1016/j.smim.2003.12.008)
  29. Alroy, I., T. L. Towers, L. P. Freedman. 1995. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15: 5789-5799. (10.1128/MCB.15.10.5789)
  30. Rigby, W. F., S. Denome, M. W. Fanger. 1987. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3: specific inhibition at the level of messenger RNA. J. Clin. Invest. 79: 1659-1664. (10.1172/JCI113004)
  31. Muller, K., K. Bendtzen. 1992. Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3: differential effects on CD45RA+ and CD45R0+ cells. Autoimmunity 14: 37-43. (10.3109/08916939309077355)
  32. Boonstra, A., F. J. Barrat, C. Crain, V. L. Heath, H. F. Savelkoul, A. O'Garra. 2001. 1α,25-Dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J. Immunol. 167: 4974-4980. (10.4049/jimmunol.167.9.4974)
  33. Mead, K. I., Y. Zheng, C. N. Manzotti, L. C. Perry, M. K. Liu, F. Burke, D. J. Powner, M. J. Wakelam, D. M. Sansom. 2005. Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells. J. Immunol. 174: 4803-4811. (10.4049/jimmunol.174.8.4803)
  34. Evans, H. G., T. Suddason, I. Jackson, L. S. Taams, G. M. Lord. 2007. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Natl. Acad. Sci. USA 104: 17034-17039. (10.1073/pnas.0708426104)
  35. McGeachy, M. J., K. S. Bak-Jensen, Y. Chen, C. M. Tato, W. Blumenschein, T. McClanahan, D. J. Cua. 2007. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat. Immunol. 8: 1390-1397. (10.1038/ni1539)
  36. Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jager, T. B. Strom, M. Oukka, V. K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448: 484-487. (10.1038/nature05970)
  37. Barrat, F. J., D. J. Cua, A. Boonstra, D. F. Richards, C. Crain, H. F. Savelkoul, R. de Waal-Malefyt, R. L. Coffman, C. M. Hawrylowicz, A. O'Garra. 2002. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195: 603-616. (10.1084/jem.20011629)
  38. Tran, D. Q., H. Ramsey, E. M. Shevach. 2007. Induction of FOXP3 expression in naive human CD4+FOXP3− T cells by T cell receptor stimulation is TGFβ-dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990. (10.1182/blood-2007-06-094656)
  39. Allan, S. E., S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, M. K. Levings. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19: 345-354. (10.1093/intimm/dxm014)
  40. Holick, M. F.. 2007. Vitamin D deficiency. N. Engl. J. Med. 357: 266-281. (10.1056/NEJMra070553)
  41. Hewison, M.. 2008. Vitamin D and innate immunity. Curr. Opin. Invest. Drugs 9: 485-490.
  42. White, J. H.. 2008. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect. Immun. 76: 3837-3843. (10.1128/IAI.00353-08)
  43. Penna, G., N. Giarratana, S. Amuchastegui, R. Mariani, K. C. Daniel, L. Adorini. 2005. Manipulating dendritic cells to induce regulatory T cells. Microbes Infect. 7: 1033-1039. (10.1016/j.micinf.2005.03.025)
  44. Adorini, L.. 2003. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann. NY Acad. Sci. 987: 258-261. (10.1111/j.1749-6632.2003.tb06057.x)
  45. Penna, G., L. Adorini. 2000. 1α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164: 2405-2411. (10.4049/jimmunol.164.5.2405)
  46. Adorini, L., G. Penna, N. Giarratana, A. Roncari, S. Amuchastegui, K. C. Daniel, M. Uskokovic. 2004. Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands. J. Steroid Biochem. Mol. Biol. 89–90: 437-441. (10.1016/j.jsbmb.2004.03.013)
  47. Hewison, M., F. Burke, K. N. Evans, D. A. Lammas, D. M. Sansom, P. Liu, R. L. Modlin, J. S. Adams. 2007. Extra-renal 25-hydroxyvitamin D3-1α-hydroxylase in human health and disease. J. Steroid Biochem. Mol. Biol. 103: 316-321. (10.1016/j.jsbmb.2006.12.078)
  48. DiPaolo, R. J., C. Brinster, T. S. Davidson, J. Andersson, D. Glass, E. M. Shevach. 2007. Autoantigen-specific TGFβ-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol. 179: 4685-4693. (10.4049/jimmunol.179.7.4685)
  49. Mathieu, C., M. Waer, J. Laureys, O. Rutgeerts, R. Bouillon. 1994. Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D3. Diabetologia 37: 552-558. (10.1007/BF00403372)
  50. Spach, K. M., F. E. Nashold, B. N. Dittel, C. E. Hayes. 2006. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 177: 6030-6037. (10.4049/jimmunol.177.9.6030)
  51. Daniel, C., N. A. Sartory, N. Zahn, H. H. Radeke, J. M. Stein. 2008. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 324: 23-33. (10.1124/jpet.107.127209)
  52. Tang, J., R. Zhou, D. Luger, W. Zhu, P. B. Silver, R. S. Grajewski, S. B. Su, C. C. Chan, L. Adorini, R. R. Caspi. 2009. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J. Immunol. 182: 4624-4632. (10.4049/jimmunol.0801543)
  53. Gorman, S., L. A. Kuritzky, M. A. Judge, K. M. Dixon, J. P. McGlade, R. S. Mason, J. J. Finlay-Jones, P. H. Hart. 2007. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J. Immunol. 179: 6273-6283. (10.4049/jimmunol.179.9.6273)
  54. Miyara, M., Z. Amoura, C. Parizot, C. Badoual, K. Dorgham, S. Trad, M. Kambouchner, D. Valeyre, C. Chapelon-Abric, P. Debre, et al 2006. The immune paradox of sarcoidosis and regulatory T cells. J. Exp. Med. 203: 359-370. (10.1084/jem.20050648)
  55. Miyara, M., Y. Yoshioka, A. Kitoh, T. Shima, K. Wing, A. Niwa, C. Parizot, C. Taflin, T. Heike, D. Valeyre, et al 2009. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911. (10.1016/j.immuni.2009.03.019)
  56. Chen, W., W. Jin, N. Hardegen, K. J. Lei, L. Li, N. Marinos, G. McGrady, S. M. Wahl. 2003. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886. (10.1084/jem.20030152)
  57. Apostolou, I., H. von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199: 1401-1408. (10.1084/jem.20040249)
  58. Liang, S., P. Alard, Y. Zhao, S. Parnell, S. L. Clark, M. M. Kosiewicz. 2005. Conversion of CD4+CD25− cells into CD4+CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 201: 127-137. (10.1084/jem.20041201)
  59. Walker, M. R., B. D. Carson, G. T. Nepom, S. F. Ziegler, J. H. Buckner. 2005. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25− cells. Proc. Natl. Acad. Sci. USA 102: 4103-4108. (10.1073/pnas.0407691102)
  60. Manzotti, C. N., H. Tipping, L. C. A. Perry, K. I. Mead, P. J. Blair, Y. Zheng, D. M. Sansom. 2002. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur. J. Immunol. 32: 2888-2896. (10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F)
  61. Takahashi, T., T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, N. Sakaguchi, T. W. Mak, S. Sakaguchi. 2000. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192: 303-310. (10.1084/jem.192.2.303)
  62. Read, S., R. Greenwald, A. Izcue, N. Robinson, D. Mandelbrot, L. Francisco, A. H. Sharpe, F. Powrie. 2006. Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J. Immunol. 177: 4376-4383. (10.4049/jimmunol.177.7.4376)
  63. Schmidt, E. M., C. J. Wang, G. A. Ryan, L. E. Clough, O. S. Qureshi, M. Goodall, A. K. Abbas, A. H. Sharpe, D. M. Sansom, L. S. Walker. 2009. CTLA-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity. J. Immunol. 182: 274-282. (10.4049/jimmunol.182.1.274)
  64. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275. (10.1126/science.1160062)
  65. Zheng, Y., C. N. Manzotti, F. Burke, L. M. Dussably, O. Qureshi, L. S. K. Walker, D. M. Sansom. 2008. Acquisition of suppressive function by activated human CD4+CD25− T cells is associated with the expression of CTLA-4 not FoxP3. J. Immunol. 181: 1683-1691. (10.4049/jimmunol.181.3.1683)
  66. Cantorna, M. T., B. D. Mahon. 2004. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. 229: 1136-1142. (10.1177/153537020422901108)
  67. Munger, K. L., L. I. Levin, B. W. Hollis, N. S. Howard, A. Ascherio. 2006. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296: 2832-2838. (10.1001/jama.296.23.2832)
Dates
Type When
Created 15 years, 10 months ago (Oct. 20, 2009, 5:42 p.m.)
Deposited 7 months, 3 weeks ago (Jan. 2, 2025, 11:41 a.m.)
Indexed 3 days, 4 hours ago (Aug. 21, 2025, 1:22 p.m.)
Issued 15 years, 9 months ago (Nov. 1, 2009)
Published 15 years, 9 months ago (Nov. 1, 2009)
Published Print 15 years, 9 months ago (Nov. 1, 2009)
Funders 0

None

@article{Jeffery_2009, title={1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP3}, volume={183}, ISSN={1550-6606}, url={http://dx.doi.org/10.4049/jimmunol.0803217}, DOI={10.4049/jimmunol.0803217}, number={9}, journal={The Journal of Immunology}, publisher={Oxford University Press (OUP)}, author={Jeffery, Louisa E. and Burke, Fiona and Mura, Manuela and Zheng, Yong and Qureshi, Omar S. and Hewison, Martin and Walker, Lucy S. K. and Lammas, David A. and Raza, Karim and Sansom, David M.}, year={2009}, month=nov, pages={5458–5467} }